comparemela.com

Latest Breaking News On - Harma biotech - Page 2 : comparemela.com

Zynerba Pharmaceuticals Inc s CBD skin gel Zygel offers a potential goldmine of therapies for Fragile X syndrome and other conditions

In addition to Fragile X Syndrome, the gel is in clinical development in patients with refractory epilepsy, autism and 22q11.2 Deletion Syndrome

United statesArmando anidoAmerican society of clinical psychopharmacologyDrug administrationGw pharmaceuticalsNew drug applicationAutism spectrum disorderAberrant behavior checklistClinical psychopharmacologyDeep diveHarma biotechZynerba pharmaceuticalsNasdaq zyne

Kazia Therapeutics Ltd eyeing commercialisation revenue after game-changing FY21

Kazia says its future success will be measured by commercialisation milestones after the company recorded its maiden revenue in the 2021 financial year.

United statesKazia cantrixilIain rossDrug administrationSimcere pharmaceuticalJames garnerRare pediatric disease designationFast track designationOasmia pharmaceuticalDeep diveSmall capsHarma biotechKazia therapeutics ltdAsx kza

Imugene Limited welcomes phase-1 trial dosing schedule for third monotherapy cohort of immunotherapy PD1-Vaxx

Clinical results continue to indicate that PD1-Vaxx is showing early signs of an immune response in patients, with antibodies to the target biomarker.

Leslie chongCohort review committeeSmall capsTc markets quotedOtcqb quotedHarma biotechImugene limitedAsx imu

FSD Pharma Inc excited to acquire pharma group Lucid Psycheceuticals to complement existing efforts

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc (CSE:HUGE) (NASDAQ:HUGE) Interim CEO Anthony Durkacz tells Proactive the group is to buy Canada-based specialty.

Anthony durkaczLucid psycheceuticals incDirector interviewsHarma biotechFsd pharmaCnsx huge

Compumedics Limited full-year results highlight improvement in revenue performance

The company continues to actively pursue step-out commercial growth opportunities for the MEG and Somfit technology platforms.

Diagnostic medical devicesMedical innovationSmall capsHarma biotechCompumedics ltdAsx cmp

vimarsana © 2020. All Rights Reserved.